OncoImmunity is a bioinformatics company offering proprietary machine-learning based software to address the key knowledge gaps in the prediction of bone fide immunogenic neoantigens for personalized cancer immunotherapy. OncoImmunity is dedicated to develop software solutions that facilitate effective patient selection for cancer immunotherapy, and identify optimal neoantigen targets for truly personalised cancer vaccines and cell therapies in a clinically actionable time-frame. Headquartered at the Oslo Cancer Cluster Incubator (OCCI), Norway, OncoImmunity AS is a private company founded in 2014 and is backed by capital financing from the Norwegian Radiumhospital Research Foundation (RadForsk), the Norwegian Cancer Society, STARTUPLAB, Grotmol Solutions, and a number of private investors.

Oslo, Norway

OncoImmunity

For the early-stage tech entrepreneurs in Norway.

StartupLab AS

STARTUPLAB

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining STARTUPLAB Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the STARTUPLAB network as they come up.

You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a STARTUPLAB company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Work for Norway's most exciting tech startups